Search Results - "Dansby, Linda M"

Refine Results
  1. 1

    How effective is rescue therapeutic plasma exchange in treatment of SARS‐Coronavirus‐2? by Diskin, Charles J., Maldonado, Ricardo, Leon, Jose, Dansby, Linda M., Carter, Thomas B., Radcliff, Lautrec, Diskin, Charles D.

    Published in Therapeutic apheresis and dialysis (01-02-2023)
    “…Introduction After the FDA gave emergency approval for the use of therapeutic plasma exchange in treatment for SARS‐Coronoavirus‐2, we analyzed its efficacy in…”
    Get full text
    Journal Article
  2. 2

    Waardenburg Syndrome With Familial Unilateral Renal Agenesis: A New Syndrome Variant? by Webb, Katie M, Smith, Alisha J, Dansby, Linda M, Diskin, Charles J

    Published in Therapeutic apheresis and dialysis (01-06-2015)
    “…A 64‐year‐old man with Waardenburg syndrome presented with anuria and was subsequently discovered by renal ultrasound to have unilateral renal agenesis. The…”
    Get full text
    Journal Article
  3. 3

    The comparative benefits of the fractional excretion of urea and sodium in various azotemic oliguric states by Diskin, Charles J, Stokes, Thomas J, Dansby, Linda M, Radcliff, Lautrec, Carter, Thomas B

    Published in Nephron. Clinical practice (01-02-2010)
    “…The fractional excretion of urea (FeUrea) may result in more reliable in the determination of renal function than sodium in the presence of oliguric azotemia;…”
    Get more information
    Journal Article
  4. 4

    Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies by Diskin, Charles J, Stokes, Thomas J, Dansby, Linda M, Radcliff, Lautrec, Carter, Thomas B

    Published in Nature clinical practice. Nephrology (01-11-2008)
    “…Maintenance of a functioning vascular access for hemodialysis is a major challenge. This Review summarizes recent insights into the pathophysiology of the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients? by DISKIN, CHARLES J, STOKES, THOMAS J, DANSBY, LINDA M, RADCLIFF, LAUTREC, CARTER, THOMAS B

    Published in Nephrology (Carlton, Vic.) (01-10-2006)
    “…Aim:  To evaluate whether factors such as acidosis and hyperphosphataemia that might cause an increased oxygen delivery to tissues could result in increased…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement by Diskin, Charles J, Stokes, Thomas J, Dansby, Linda M, Radcliff, Lautrec, Carter, Thomas B

    Published in International urology and nephrology (01-01-2007)
    “…While calcium carbonate is known to interfere with the gastrointestinal absorption of levothyroxine, we hypothesized that other phosphate binders would also…”
    Get full text
    Journal Article
  10. 10

    Recurrent metabolic alkalosis and elevated troponins after crack cocaine use in a hemodialysis patient by Diskin, Charles J, Stokes, Thomas J, Dansby, Linda M, Radcliff, Lautrec, Carter, Thomas B

    Published in Clinical and experimental nephrology (01-06-2006)
    “…When acid-base disorders have been described after cocaine use, they are usually metabolic acidosis. We report a case of recurrent crack cocaine use associated…”
    Get full text
    Journal Article
  11. 11

    The first fistula: influence of location on catheter use and the influence of catheter use on maturation by Diskin, Charles J., Stokes, Thomas J., Dansby, Linda M., Radcliff, Lautrec, Carter, Thomas B., Lazenby, Allen

    Published in International urology and nephrology (01-09-2015)
    “…Background The forearm location for the initial vascular access has traditionally been considered the most desirable; however, recent advances in our…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The prevalence and meaning of eosinophilia in renal diseases on a nephrology consultation service by Diskin, Charles J., Stokes, Thomas J., Dansby, Linda M., Radcliff, Lautrec, Carter, Thomas B.

    Published in Nephrology, dialysis, transplantation (01-08-2011)
    “…Background. In recent years, we have come to understand that the eosinophil is more than the end point in clearance of parasitic infection or a maladaptive…”
    Get full text
    Journal Article
  14. 14

    Toward the optimal clinical use of the fraction excretion of solutes in oliguric azotemia by Diskin, Charles J, Stokes, Thomas J, Dansby, Linda M, Radcliff, Lautrec, Carter, Thomas B

    Published in Renal failure (01-11-2010)
    “…While the fractional excretion of solutes have long been considered excellent research tools to investigate tubular physiology, their clinical use has become…”
    Get more information
    Journal Article
  15. 15

    Beyond Anemia: The Clinical Impact of the Physiologic Effects of Erythropoietin by Diskin, Charles J., Stokes, Thomas J., Dansby, Linda M., Radcliff, Lautrec, Carter, Thomas B.

    Published in Seminars in dialysis (01-09-2008)
    “…Although we have known that oxygen tension affects erythrocyte production since the 19th century, we have only recently begun to understand many subtleties of…”
    Get full text
    Journal Article
  16. 16

    Can the combination of calcium and parathormone levels above k/doqi guidelines be used as a marker of adynamic bone disease in African Americans? by Diskin, Charles J., Stokes, Thomas J., Dansby, Linda M., Radcliff, Lautrec, Carter, Thomas B.

    Published in International urology and nephrology (01-12-2011)
    “…Background Patients of African American descent are at risk for the development of adynamic bone disease at parathyroid hormone levels 50% above the K/DOQI…”
    Get full text
    Journal Article
  17. 17

    A hypothesis: can erythropoietin administration affect the severity of retinopathy in diabetic patients with renal failure? by Diskin, Charles J, Stokes, Thomas J, Dansby, Linda M, Radcliff, Lautrec, Carter, Thomas B

    “…Before the clinical availability of erythropoietin, diabetic retinopathy was known to stabilize on dialysis. Recently erythropoietin has been shown to be a…”
    Get more information
    Journal Article
  18. 18

    Removal of methotrexate by peritoneal dialysis and hemodialysis in a single patient with end-stage renal disease by Diskin, Charles J, Stokes, Thomas J, Dansby, Linda M, Radcliff, Lautrec, Carter, Thomas B

    “…Although methotrexate is highly bound to albumin, it is thought to be removed by hemodialysis and not by peritoneal dialysis. We are not aware of any direct…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Can omeprazole reduce the incidence of hypercalcemia in dialysis patients using calcium containing phosphate binders? by Diskin, Charles J, Stokes, Thomas J, Dansby, Linda M, Radcliff, Lautrec, Carter, Thomas B

    Published in Journal of nephrology (01-07-2010)
    “…Calcium absorption from the bowel is known to depend upon gastric acidity. We chose to investigate whether the use of omeprazole could reduce the incidence of…”
    Get more information
    Journal Article